APONTIS PHARMA AG revenue breakdown overview

APONTIS PHARMA AG revenue for the last year amounted to 48.80 M EUR, the most of which — 34.42 M EUR — came from its highest performing source at the moment, Single Pills, the year earlier bringing 25.64 M EUR. The greatest contribution to the revenue figure was made by Germany — last year it brought APONTIS PHARMA AG 48.47 M EUR, and the year before that — 36.96 M EUR.